5-Methylimidazo[1,2-a]pyridine-2-carboxylic acid, 95.0%, 5g

1-(3-(4-CHLOROPHENOXY)PHENYL)UREA, 95.0%, 250mg

Tetrahydrothiopyran-4-one oxime, 97%, 100g

4-Chloro-1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 98%, 100mg

Xantphos, min. 98%, 5 g, glass packaging

5-Cyclopropyl-1,3,4-oxadiazole-2-carbaldehyde, 5g

Dimethyl 1,3-Acetonedicarboxylate>95.0%(GC)500g

3-(Trifluoromethyl)-1H-pyrazolo[3,4-b]pyridine, 95.0%, 5g

Methyl 5-bromo-1H-pyrrole-2-carboxylate, 95.0%, 5g

(3aR,4R,6S,6aS)-Methyl 4-((tert-butoxycarbonyl)amino)-3-(pentan-3-yl)-4,5,6,6a-tetrahydro-3aH-cyclopenta[d]isoxazole-6-carboxylate, 95.0%, 1g

2-Phenoxy-N-methylethylamine hydrochloride, 95.0%, 250mg

2-(2-(Difluoromethyl)-4,5-difluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 250mg

2,2-Bis(3-amino-4-hydroxyphenyl)propane, 97.0%, 100g